Phase IV Open Label Single Group One Year Study Of Home Self-injection With Sayana (Registered) Press In Adult Women Of Reproductive Age - A Pragmatic Clinical Trial
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Jun 2018
At a glance
- Drugs Medroxyprogesterone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Pfizer
- 18 Jun 2018 Planned End Date changed from 6 Dec 2018 to 8 Dec 2018.
- 18 Jun 2018 Planned primary completion date changed from 6 Dec 2018 to 8 Dec 2018.
- 18 Jun 2018 Status changed from recruiting to active, no longer recruiting.